Bayesian Health logo

Bayesian Health

FDA-cleared continuous AI sepsis monitor with a dedicated Medicare add-on payment.

ShareLink copied

The record

Vertical
Clinical AI & Documentation
Sub-segment
Real-time clinical decision support
Product type
Software as a medical device
Stage
Private
Headquarters
New York, NY
Region
North America

What they do

Bayesian Health builds real-time clinical AI that flags patients at risk of sepsis earlier inside existing hospital workflows. Its sepsis flagging device received FDA Breakthrough designation and FDA clearance in April 2026, and was approved for a Medicare New Technology Add-on Payment under the CMS FY 2027 inpatient rule, effective October 1, 2026. Founder and CEO Suchi Saria, PhD, leads the company.

Leadership & founders

Leadership as of 14 November 2026.

In The HealthTech Signal

Related companies

Is this your company? Get a Verified profile